Hepatic disease in erythropoietic protoporphyria

Area of Science:

• Hepatology
• Medical Genetics
• Biochemistry

Background:

• Erythropoietic protoporphyria (EPP) is a rare genetic disorder.
• EPP is characterized by the accumulation of protoporphyrin in erythrocytes and plasma.
• Hepatic complications are a known, though less common, manifestation of EPP.

Purpose of the Study:

• To investigate the spectrum of liver disease in patients with erythropoietic protoporphyria.
• To elucidate the pathological changes associated with hepatic involvement in EPP.
• To highlight the potential for rapid progression to fatal liver failure in EPP.

Main Methods:

• Case study of two sisters with EPP and varying degrees of liver disease.
• Clinical assessment including liver function tests (bromsulfalein retention, transaminases) and jaundice.
• Histopathological examination of liver biopsy and autopsy specimens, including assessment of protoporphyrin deposition.

Main Results:

• One sister developed severe, rapidly progressive liver disease culminating in fatal hepatic failure within months of jaundice onset.
• The second sister exhibited milder liver abnormalities with less pronounced histopathological findings.
• Massive protoporphyrin deposition was observed in Kupffer cells, histiocytes, bile canaliculi, and hepatocytes in the advanced case.

Conclusions:

• Significant and progressive hepatic disease can develop insidiously in erythropoietic protoporphyria.
• The onset of jaundice in EPP may herald a rapid and fatal course of liver failure.
• Close monitoring of liver function is essential in patients with EPP.